ATCC lands $250m from BARDA for COVID-19 services
The contract, with a ceiling value of $250M and potential length of 10 years, will supplement the company’s ongoing support of virus-related work.
Archives for October 6, 2020
First patient dosed in long-term Alzheimer’s trial
Neurotrope has kicked off its ongoing Phase II study of Bryostatin-1 for treatment of Alzheimer’s disease, with the help of a $2.7m NIH grant.
Premier Research: holistic approach benefits drug development
A leader from the CRO shares insights as to what strategies and philosophies work best when working to craft a successful drug development program.